-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AGK1CcM+AX0+Dr7urWBi9tNmzBJ8PgPaBdNptmH/Raz9eatx9cpE21TwpZ/ijsmD F7zuLEWQCpnsPbjl2Q6tVA== /in/edgar/work/20000728/0000906337-00-000010/0000906337-00-000010.txt : 20000921 0000906337-00-000010.hdr.sgml : 20000921 ACCESSION NUMBER: 0000906337-00-000010 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000720 FILED AS OF DATE: 20000728 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PROXYMED INC /FT LAUDERDALE/ CENTRAL INDEX KEY: 0000906337 STANDARD INDUSTRIAL CLASSIFICATION: [7374 ] IRS NUMBER: 650202059 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 000-22052 FILM NUMBER: 680571 BUSINESS ADDRESS: STREET 1: 2555 DAVIE ROAD STREET 2: SUITE 110 CITY: FORT LAUDERDALE STATE: FL ZIP: 33317-7424 BUSINESS PHONE: 9544731001 FORMER COMPANY: FORMER CONFORMED NAME: HMO PHARMACY INC DATE OF NAME CHANGE: 19930601 COMPANY DATA: COMPANY CONFORMED NAME: CRAMER GERALD B CENTRAL INDEX KEY: 0001023982 STANDARD INDUSTRIAL CLASSIFICATION: [ ]DIRECTOR FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: PROXYMED STREET 2: 2555 DAVIE RD STE 110 CITY: FT LAUDERDALE STATE: FL ZIP: 33317 BUSINESS PHONE: 9544731001 MAIL ADDRESS: STREET 1: PROXYMED STREET 2: 2555 DAVIE RD STE 110 CITY: FT LAUDERDALE STATE: FL ZIP: 33317 3 1 0001.txt FORM 3 - 07/20/00 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 1. Name and Address of Reporting Person Cramer, Gerald B 707 Westchester Avenue White Plains, NY 10604 USA 2. Date of Event Requiring Statement (Month/Day/Year) 07/20/00 3. IRS or Social Security Number of Reporting Person (Voluntary) ###-##-#### 4. Issuer Name and Ticker or Trading Symbol ProxyMed, Inc. PILL 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) (X) Director ( ) 10% Owner ( ) Officer (give title below) ( ) Other (specify below) Director 6. If Amendment, Date of Original (Month/Day/Year) 7. Individual or Joint/Group Filing (Check Applicable Line) (X) Form filed by One Reporting Person ( ) Form filed by More than One Reporting Person
___________________________________________________________________________________________________________________________________ Table I -- Non-Derivative Securities Beneficially Owned | ___________________________________________________________________________________________________________________________________| 1. Title of Security |2. Amount of |3. Ownership |4. Nature of Indirect | | Securities | Form: | Beneficial Ownership | | Beneficially | Direct(D) or | | | Owned | Indirect(I) | | ___________________________________________________________________________________________________________________________________| Common Stock, par value $.001 |3,750 |I |Partnership with children | - -----------------------------------------------------------------------------------------------------------------------------------| Common Stock, par value $.001 |6,000 |I |Spousal Account | - -----------------------------------------------------------------------------------------------------------------------------------| Common Stock, par value $.001 |75,000 |D | | - -----------------------------------------------------------------------------------------------------------------------------------| Common Stock, par value $.001 |77,125 |D | | - -----------------------------------------------------------------------------------------------------------------------------------| Common Stock, par value $.001 |77,125 |D | | - -----------------------------------------------------------------------------------------------------------------------------------| Common Stock, par value $.001 |10,000 |I |Brother | - -----------------------------------------------------------------------------------------------------------------------------------| Common Stock, par value $.001 |5,000 |I |Sister | - -----------------------------------------------------------------------------------------------------------------------------------| ___________________________________________________________________________________________________________________________________| ___________________________________________________________________________________________________________________________________ Table II -- Derivative Securitites Beneficially Owned | ___________________________________________________________________________________________________________________________________| 1.Title of Derivative |2.Date Exer- |3.Title and Amount | |4. Conver-|5. Owner- |6. Nature of Indirect | Security | cisable and | of Underlying | |sion or |ship | Beneficial Ownership | | Expiration | Securities | |exercise |Form of | | | Date(Month/ |-----------------------|---------|price of |Deriv- | | | Day/Year) | |Amount |deri- |ative | | | Date | Expira- | |or |vative |Security: | | | Exer- | tion | Title |Number of|Security |Direct(D) or | | | cisable | Date | |Shares | |Indirect(I) | | ___________________________________________________________________________________________________________________________________| Warrant |6/10/99 |6/10/04 |Common Stock, par value|14,167 |$10.00 |D |Trust - Personal | | | | $.001 | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| Warrant |6/10/99 |6/10/04 |Common Stock, par value|14,167 |$10.00 |I |Trust - Joint | | | | $.001 | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| Warrant |07/07/01*|6/28/05 |Common Stock, par value|125,000 |$1.00** |D |Trust - Personal | | | | $.001 | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| Warrant |07/07/01*|6/28/05 |Common Stock, par value|125,000 |$1.00** |I |Trust - Joint | | | | $.001 | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| Warrant |07/07/01*|6/28/05 |Common Stock, par value|50,000 |$1.00** |I |Brother | | | | $.001 | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| Series C 7% Convertible |N/A* |N/A |Preferred convertible i|250,000 |$1.00 |D |Trust - Personal | Preferred Stock | | |nto Common w/optional &| | | | | | | | Mandatory conversion r| | | | | | | |ights | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| Series C 7% Convertible |N/A* |N/A |" |250,000 |$1.00 |I |Trust - Joint | Preferred Stock | | | | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| Series C 7% Convertible |N/A* |N/A |" |100,000 |$1.00 |I |Brother | Preferred Stock | | | | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| ___________________________________________________________________________________________________________________________________|
Explanation of Responses: *Conversion and Warrant Shares are subject to a 12-month lockup, which may be extended an additional 12 months at the discretion of the Placement Agent. **Subject to anti-dilution adjustments as provided in the Warrant Agreement. SIGNATURE OF REPORTING PERSON Gerald B. Cramer DATE July 26, 2000 -----END PRIVACY-ENHANCED MESSAGE-----